Literature DB >> 10749014

Liposomes as vehicles for targeted therapy of cancer. Part 1: preclinical development.

K J Harrington1, C R Lewanski, J S Stewart.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10749014     DOI： 10.1053/clon.2000.9104

Source DB:  PubMed          Journal:  Clin Oncol (R Coll Radiol)        ISSN： 0936-6555            Impact factor:   4.126


× No keyword cloud information.
  4 in total

Review 1.  Nanotargeted radionuclides for cancer nuclear imaging and internal radiotherapy.

Authors:  Gann Ting; Chih-Hsien Chang; Hsin-Ell Wang; Te-Wei Lee
Journal:  J Biomed Biotechnol       Date:  2010-08-03

Review 2.  The use of convection-enhanced delivery with liposomal toxins in neurooncology.

Authors:  Massimo S Fiandaca; Mitchel S Berger; Krystof S Bankiewicz
Journal:  Toxins (Basel)       Date:  2011-03-31       Impact factor: 4.546

3.  Spatial dose distributions in solid tumors from 186Re transported by liposomes using HS radiochromic media.

Authors:  Luis A Medina; Beth Goins; Mercedes Rodríguez-Villafuerte; Ande Bao; Arnulfo Martínez-Davalos; Vibhudutta Awasthi; Olga O Galván; Cristina Santoyo; William T Phillips; María-Ester Brandan
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-02-08       Impact factor: 10.057

4.  Targeted radiosensitisation by pegylated liposome-encapsulated 3', 5'-O-dipalmitoyl 5-iodo-2'-deoxyuridine in a head and neck cancer xenograft model.

Authors:  K J Harrington; K N Syrigos; P S Uster; A Zetter; C R Lewanski; W J Gullick; R G Vile; J S W Stewart
Journal:  Br J Cancer       Date:  2004-07-19       Impact factor: 7.640
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.